3 Rock-Solid Pharma Stocks to Buy Now and Hold Forever
https://www.fool.com/investing/2024/08/30/3-rock-solid-pharma-stocks-to-buy-now-and-hold-for/?source=iedfolrf0000001
Aug 30, 2024 - These three have secure core businesses, plus multiple paths to grow.
0
3 Unstoppable Dividend Stocks to Buy Right Now
https://www.fool.com/investing/2024/08/25/3-unstoppable-dividend-stocks-to-buy-right-now/?source=iedfolrf0000001
Aug 25, 2024 - These stocks are the A-team for income investors.
0
Pharma Stock Roundup: FDA Nod to PFE, MRNA New COVID Jabs & More
https://www.zacks.com/stock/news/2326355/pharma-stock-roundup-fda-nod-to-pfe-mrna-new-covid-jabs-more?cid=CS-ZC-FT-analyst_blog|stock_roundup-2326355
Aug 23, 2024 - LLY's phase III study shows that tirzepatide reduces the risk of developing type II diabetes. FDA approves PFE and MRNA's updated COVID-19 vaccine.
0
AbbVie (ABBV) Gets Nod in EU for Lymphoma Drug's Expanded Use
https://www.zacks.com/stock/news/2324436/abbvie-abbv-gets-nod-in-eu-for-lymphoma-drug-s-expanded-use?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2324436
Aug 20, 2024 - AbbVie's (ABBV) Tepkinly gets conditional approval in the EU to treat third-line patients with relapsed or refractory follicular lymphoma as a second indication.
0
Should iShares Core High Dividend ETF (HDV) Be on Your Investing Radar?
https://www.zacks.com/stock/news/2324124/should-ishares-core-high-dividend-etf-hdv-be-on-your-investing-radar?cid=CS-ZC-FT-style_box_etf-2324124
Aug 20, 2024 - Style Box ETF report for HDV
0
3 High-Yielding Dividend Growth Stocks That Retirees Can Rely On for Recurring Income
https://www.fool.com/investing/2024/08/17/3-high-yielding-dividend-growth-stocks-that-retire/?source=iedfolrf0000001
Aug 17, 2024 - These stocks all pay more than 3%, and they have been regularly increasing their payouts in recent years.
0
Top Research Reports for Alphabet, AbbVie & QUALCOMM
https://www.zacks.com/commentary/2321068/top-research-reports-for-alphabet-abbvie-qualcomm?cid=CS-ZC-FT-research_daily-2321068
Aug 13, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Alphabet Inc. (GOOGL), AbbVie Inc. (ABBV) and QUALCOMM Incorporated (QCOM), as well as a micro-cap stock Flanigan's Enterprises, Inc. (BDL).
0
3 Big Drug Stocks to Watch on Raised 2024 Earnings & Sales View
https://www.zacks.com/stock/news/2321388/3-big-drug-stocks-to-watch-on-raised-2024-earnings-sales-view?cid=CS-ZC-FT-analyst_blog|investment_ideas-2321388
Aug 13, 2024 - Here we discuss three drugmakers, Eli Lilly and Company (LLY), Pfizer (PFE) and AbbVie (ABBV), following their increase in sales and earnings guidance for 2024.
0
Ironwood (IRWD) Q2 Earnings & Revenues Fall Shy of Estimates
https://www.zacks.com/stock/news/2320139/ironwood-irwd-q2-earnings-revenues-fall-shy-of-estimates?cid=CS-ZC-FT-analyst_blog|earnings_article-2320139
Aug 09, 2024 - Ironwood (IRWD) reports breakeven earnings for second-quarter 2024. Revenues miss estimates. The company lowers revenue guidance for 2024. Stock falls.
0
How Should You Play AstraZeneca (ABBV) After Q2 Beat, View Raise?
https://www.zacks.com/stock/news/2316191/how-should-you-play-astrazeneca-abbv-after-q2-beat-view-raise?cid=CS-ZC-FT-analyst_blog|rank_focused-2316191
Aug 05, 2024 - AstraZeneca's (AZN) key drugs like Lynparza, Tagrisso, Imfinzi, Ultomiris and Farxiga should drive sales. Its pipeline is huge, with several candidates having blockbuster potential.
0